References
- Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15(7):387–407. doi:10.1038/s41569-018-0007-y.
- Frey N, Olson EN. Cardiac hypertrophy: The good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45–79. doi:10.1146/annurev.physiol.65.092101.142243.
- Rosca MG, Hoppel CL. Mitochondrial dysfunction in heart failure. Heart Fail Rev. 2013;18(5):607–22. doi:10.1007/s10741-012-9340-0.
- Dorn GW 2nd. Mitochondrial dynamism and heart disease: Changing shape and shaping change. EMBO Mol Med. 2015;7(7):865–77. doi:10.15252/emmm.201404575.
- Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, Neufer PD. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol. 2009;54(20):1891–8. doi:10.1016/j.jacc.2009.07.031.
- Kiyuna LA, Albuquerque RPE, Chen CH, Mochly-Rosen D, Ferreira JCB. Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities. Free Radic Biol Med. 2018;129:155–68. doi:10.1016/j.freeradbiomed.2018.09.019.
- Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56(2):185–229. doi:10.1124/pr.56.2.6.
- Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, Hoppel CL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem. 2004;279(46):47961–7. doi:10.1074/jbc.M409720200.
- Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol. 2012;52(6):1213–25. doi:10.1016/j.yjmcc.2012.03.006.
- Chen YR, Zweier JL. Cardiac mitochondria and reactive oxygen species generation. Circ Res. 2014;114(3):524–37. doi:10.1161/CIRCRESAHA.114.300559.
- Rodrigo R, Libuy M, Feliú F, Hasson D. Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction. Biomed Res Int. 2013;2013:437613. doi:10.1155/2013/437613.
- Nagarajan A, Doss VA. L-carvone from Mentha spicata L. leaves suppresses oxidative stress and hypertrophy in the isoproterenol-induced rat model of cardiac hypertrophy. Tradit Integr Med. 2024;9(1):24–35.
- Nagarajan A, Doss VA. L-carvone attenuates myocardial injury and dyslipidemia in rats with isoproterenol-induced cardiac hypertrophy. Asian Pac J Trop Biomed. 2023;13(1):17–25. doi:10.4103/2221-1691.367687.
- Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464–71. doi:10.1016/j.tcb.2014.04.002.
- Joseph LC, Subramanyam P, Radlicz C, Trent CM, Iyer V, Colecraft HM, et al. Mitochondrial oxidative stress during cardiac lipid overload causes intracellular calcium leak and arrhythmia. Heart Rhythm. 2016;13(8): 1699–706. doi:10.1016/j.hrthm.2016.05.002.
- Canto C, Auwerx J. Targeting sirtuin 1 to improve metabolism: All you need is NAD(+)? Pharmacol Rev. 2012;64(1):166–87. doi:10.1124/pr.110.003905.
- Pina LTS, Serafini MR, Oliveira MA, Sampaio LA, Guimarães JO, Guimarães AG. Carvone and its pharmacological activities: A systematic review. Phytochemistry. 2022;196:113080. doi:10.1016/j.phytochem.2021.113080.
- de Cássia da Silveira e Sá R, Andrade LN, de Sousa DP. A review on anti-inflammatory activity of monoterpenes. Molecules. 2013;18(1):1227–54. doi:10.3390/molecules18011227.
- Franco R, Serrano-Marín J. Robustness of the Krebs cycle under physiological conditions and in cancer: New clues for evaluating metabolism-modifying drug therapies. Biomedicines. 2022;10(5):1199. doi:10.3390/biomedicines10051199.
- Kloska S, Pałczyński K, Marciniak T, Talaśka T, Nitz M, Wysocki BJ, et al. Queueing theory model of Krebs cycle. Bioinformatics. 2021;37(18):2912–9.
- Oliphant TE. SciPy: Open source scientific tools for Python. Comput Sci Eng. 2007;9(1):10–20.
- Duchesnay E, Lofstedt T, Younes F. Statistics and machine learning in Python. Engineering School, France; 2025. HAL Id: hal-03038776v5.
- Otter M, Csader S, Keiser M, Oswald S. Expression and functional contribution of different organic cation transporters to the cellular uptake of doxorubicin into human breast cancer and cardiac tissue. Int J Mol Sci. 2022;23(1):255. doi:10.3390/ijms23010255.
- Jager W, Mayer M, Platzer P, Reznicek G, Dietrich H, Buchbauer G. Stereoselective metabolism of the monoterpene carvone by rat and human liver microsomes. J Pharm Pharmacol. 2000;52(2):191–7. doi:10.1211/0022357001773841.
- Saganuwan SA. Application of modified Michaelis-Menten equations for determination of enzyme-inducing and -inhibiting drugs. BMC Pharmacol Toxicol. 2021; 22(1):57. doi:10.1186/s40360-021-00521-x.
- Wu R. Rate-limiting factors in glycolysis and inorganic orthophosphate transport in rat liver and kidney slices. Exp Mol Pathol. 1965;240(6):2373–81.
- Nagarajan A, Doss VA. Tissue slice preparation for metabolic studies using an improvised ice-embedded tissue using hand plane. Indian Patent Appl No. 202541001438 A. The Patent Office Journal. 2025;3:7441.
- Nagarajan A, Doss VA. A new tissue slice technique for evaluation of cardiac tissue enzymes and metabolites. Sci J Sci Technol. 2024;46(6):545–50.
- Yasumi M, Minaga T, Nakamura K, Kizu A, Ijichi H. Inhibition of cardiac NADP-linked isocitrate dehydrogenase by adriamycin. Biochem Biophys Res Commun. 1980;93(2):631–6.
- Silva GBAD, Souza DS, Menezes-Filho JER, Silva-Neto JAD, Cruz JDS, et al. (-)-Carvone modulates intracellular calcium signaling with antiarrhythmic action in rat hearts. Arq Bras Cardiol. 2022;119(2):294–304.
- Kwofie SK, Broni E, Yunus FU, Nsoh J, Adoboe D, Miller WA, et al. Molecular docking simulation studies identifies potential natural product-derived antiwolbachial compounds as filaricides against Onchocerciasis. Biomedicines. 2021;9(11):1682. doi:10.3390/biomedicines9111682.
- Zullo A, Guida R, Sciarrillo R, Mancini FP. Redox homeostasis in cardiovascular disease: The role of mitochondrial sirtuins. Front Endocrinol (Lausanne). 2022;13:858330. doi:10.3389/fendo.2022.858330.